Objectives: Ninety percent of head and neck cancers are squamous cell carcinoma which develops in the oral cavity. Metastasis is the main causative factor for death in 90% of all cancer-related deaths and begins with the invasion of tumor cells through the walls of small blood vessels or lymph vessels. A growing body of evidence has shown that vasculogenic mimicry (VM) facilitates tumor growth and cancer metastasis. The current study aimed to present the role of vascular endothelial (VE)-cadherin, CD44, and vimentin in inducing VM and epithelial-mesenchymal transition (EMT) and to identify the cancer stem cell (CSC) niche in different grades of oral squamous cell carcinoma (OSCC).
Introduction
H ead and neck cancer is the sixth most common cancer in the world. [1] Ninety percent of head and neck cancers are squamous cell carcinoma which develops in the oral cavity. [2, 3] Metastasis is the main causative factor for death in 90% of all cancer-related deaths [4] [5] [6] cancer cells settle into a niche to promote proliferation and vasculogenesis. [7, 9] Folkman first proposed a theory regarding tumor angiogenesis. According to this theory, a tumor forms new vasculature from existing blood vessels. [10] Maniotis et al. indicated that the vascular-like channels which function as tumor blood vessels were formed in melanoma. This phenomenon was called "vasculogenic mimicry" (VM). [11] A growing body of evidence has shown that VM formation facilitates tumor growth and cancer metastasis. [12] Previously published works have shown that VM indicates a poor prognosis in oral squamous cell carcinoma (OSCC). [13] Vascular endothelial-cadherin (VE-cadherin), an adhesive protein, promotes cell-to-cell interaction. Recently, VE-cadherin has been demonstrated in both endothelial cells and highly aggressive melanoma cells. [14] Overexpression level of VE-cadherin enhances the cancer neovascularization, growth, and progression. [15, 16] On the other hand, a small subset of tumor cells involves in cancer development. These cells, cancer stem cells (CSCs), not only are able to reproduce the whole phenotype of the original tumor but also are capable of self-renewal. [17] It is suggested that CSCs may also be involved in vascular formation in cancers. [18] Previous publications have shown that CSCs can induce epithelial-mesenchymal transition (EMT) to promote tumor cell invasion and metastasis. [19] CD44, a cell-surface glycoprotein, involves in cell-cell interactions, cell migration, and adhesion. For this reason, it plays a major role in tumorigenesis and metastasis. [20] Furthermore, CD44 has been described as a CSC marker in head and neck squamous cell carcinoma (HNSCC) and can re-establish the tumor heterogeneity. [21] Increased CD44 expression level has been detected in cancers such as HNSCC. [22] There are controversial results regarding to CD44 expression level in OSCC and lymph node metastasis. While Fonseca et al, and Lindquist et al. indicated a positive relationship between high CD44 expression and lymph-node metastasis, [23, 24] Mostaan et al., and Rodrigo et al. found a correlation between low CD44 expression and capability for metastasis. [25, 26] Vimentin, a mesenchymal marker, plays a crucial role in EMT. [16, 27] In some cancers such as esophageal squamous cell carcinoma, the increased expression level of vimentin is associated with a higher incidence of lymph node metastasis. [28, 29] Recently, studies have shown that CSC and EMT enhance VM formation through stimulating cancer cell plasticity, remodeling the extracellular matrix, and connecting VM channels with host blood vessels, [30] but the regulatory mechanism is still unclear. The identification of biomarkers related to EMT, CSCs, and VM may provide a chance to develop drugs targeting EMT, CSC, and VM formation. [31, 32] VM can be identified by the detection of periodic acid-Schiff (PAS)-positive loops surrounded by tumor cells (not endothelial cells), with or without red blood cells in it. [12] The current study aimed to present the role of VE-cadherin, CD44, and vimentin in inducing VM and EMT and to identify the CSC niche in different grades of OSCC.
Materials and Methods
Patients and tissue samples PASS software (power analysis and sample size) software (version 11.0.7; PASS, NCSS, LLC) was used to calculate the sample size using the following information: DF = 4, effect size = 0.5, power (1−β) = 0.9, and alpha (significance level) = 0.05.
A total of 63 OSCC samples (21 samples each grade) were collected from the archive of Pathology Department of Besat Educational Hospital, Hamadan, Iran, from 2000 to 2015. Institutional Review Board approval number was 9409034804.
There were 25 cases from the tongue, 15 cases from the buccal mucosa and 13 cases from gingiva, and 10 cases from floor of mouth. Adjacent normal oral mucosa served as control group. Hematoxylin and eosin staining was performed to confirm the previous diagnosis. Histologically, OSCCs were classified as low, intermediate, or high grade on the basis of the presence of cytological atypia, keratin pearl, mitotic activity, and other criteria. [33] Double immunohistochemistry/periodic acid-Schiff staining The specimens were processed for immunohistochemistry analysis. Monoclonal anti-mouse IgG antibodies used in the immunohistochemistry assay were vimentin (Novocastra™ ready to use) and CD44 (1:200; Thermo Scientific, Std./HCAM Ab-4). Polyclonal anti-rabbit VE-cadherin antibody (1:170; Abcam; 33168) was used as well. Then, the sections were stained with PAS. Briefly, tissue sections were cut by 4 mm thickness. Then, the sections were deparaffinized and dehydrated with graded alcohol. The antigen retrieval was done in citrate buffer (pH = 6) for CD44 and vimentin and in EDTA/Tris (pH = 9) for VE-cadherin. Using Leica detection kit, endogenous peroxidase activity was blocked. After 3 washes in Tris-buffered saline (TBS), the samples were incubated with primary antibodies for 1 h. Negative controls were prepared by omitting the primary antibody. The positive control staining was also performed (reactive lymph node according to the manufacturer instructions). After TBS washing, the slides were developed in freshly prepared diaminobenzidine solution for 6 min. Then, PAS staining was performed, followed by counterstaining with hematoxylin, dehydration, and mounting.
Detection and scoring VE-cadherin and CD44 expression was detected in the membrane of the tumor cells. Vimentin expression was detected in the cytoplasm of cancer cells. Microvessel density (MVD) was determined by light microscopy examination of stained sections at the "hot spot." Fields of the greatest neovascularization were identified by light microscope at low power (×100). The average vessel count of the five fields (×400) was regarded as the MVD count. The MVD was classified as either high (≥15) or low (<15); 15 was considered as the median value of MVD in our study. VM was also assessed. VE-cadherin, CD44, and vimentin/PAS double-staining were used to validate VM. VM was identified by the detection of PAS-positive loops surrounded by tumor cells (not endothelial cells), with or without red blood cells in it. The abundance of positive cells for biomarkers was graded as follows: 1 (weak) for <20% positive cells, 2 (moderate) for 20%-50% positive cells, and 3 (strong) for >50% positive cells. [16] Statistical analysis Analyses were conducted through SPSS software version 22.0 (SPSS, Inc., Chicago, IL, USA). Chi-Square test was used to examine the differences between the variables. Significant level was set at 0.05. Pearson's correlation was used to assess the co-localization of the markers.
Results
A total of 63 samples (40 men; 63.5%, and 23 women; 36.5%) were used for immunohistochemical study. Age ranged from 20 to 70 years with a mean age of 53.3 years. There were statistically significant differences between tumor grade and the expression levels of VE-cadherin, CD44, and vimentin (P = 0.000). In addition, significant differences were found between tumor grade and MVD (P = 0.000) and between tumor grade and VM (P = 0.000). Besides, there was a positive correlation between tumor grade and VEcadherin expression level Pearson r = 0.925, P < 0.000) between tumor grade and CD44 expression level (Pearson r = 0.595, P < 0.000), and between tumor grade and vimentin expression level (Pearson r = 0.678, P < 0.000). The details are summarized in Table 1 .
Discussion
In this study, the expression level of VE-cadherin, CD44, and vimentin was examined in different histological grades of OSCC. According to the previous studies, VM formation is seen involving in tumor growth and cancer metastasis, [11] and in OSCC, it is correlated to poor prognosis. [9] In addition, the elevated expression level of VE-cadherin is associated with the cancer growth and progression. [16] Besides, VE-cadherin is expressed by CSCs and is associated with VM. [34, 35] A study on aggressive melanoma indicated the high expression level of VE-cadherin by cancer cells. The authors suggested that VE-cadherin expression by tumor cells enhances vasculogenic-like network formation. Furthermore, it is suggested that tumor plasticity allows VM formation which is correlated to the VE-cadherin expression. [14] VM formation has a crucial role in the tumor progression and metastasis. [18] Overexpression of VE-cadherin in cancers such as melanoma and breast cancer is associated with poor prognosis. [34] In a published work, Fry et al. suggested VE-cadherin expression as a metastatic biomarker in breast cancer. [35] VM and EMT promote invasion and metastasis. [36, 37, 38] During VM formation, highly aggressive epithelial tumor cells can overexpress the mesenchymal phenotype through EMT. [39] VM has been shown to present in 21/84 (25%) of gastrointestinal stromal tumors, which were significantly associated with tumor grade and liver metastasis. [38] In a previous study on OSCC, tumor cell-lined vessels were found in 18/33 (54.5%) of cases. [13] Besides, VM formation was found in 40% of adenoid cystic carcinoma (ACC) tissues, mainly in the solid pattern. [19] Importantly, a published work on the triple-negative breast cancer demonstrated a significant expression level of VE-cadherin in CD133+ CSCs. The authors proposed that CD133+ CSCs might have the ability of acquisition of endothelial cell phenotype and VE-cadherin expression to enhance VM formation. [39] In our study, strong expression level of VE-cadherin was found in all high-grade samples. In addition, VM formation (lined by VE-cadherin-positive cancer cells) was detected in 17 (81%) of intermediate-grade and 18 (85.7%) of high-grade samples [Figures 1 and 2 ]. Furthermore, VM channels lined by VE-cadherin-positive cancer cells were mostly detected in histologically higher degree samples and the VE-cadherin expression level increased by the increasing of tumor grade increase. The present study also demonstrated VE-cadherin positivity at invasive front [ Figure 3 ]. These results may provide sufficient document for the role of VE-cadherin expression level and VM formation in the tumor growth and the risk of metastasis through CSCs and EMT. Moreover, VE-cadherin expression level is suggested as a metastatic biomarker for OSCC.
Regarding CD44 expression level in the present study, strong CD44 expression was found in all high-grade samples and 13 (61.9%) of intermediate-grade samples [Figures 4 and 5] . Besides, CD44-positive cancer cells were mainly found at invasive front and at the periphery of tumor islands [ Figure 6 ]. Therefore, the present study provides enough evidence that the number of CSCs also increases by the increase of histological degree, and also, CD44 and VE-cadherin enhance tumor growth and metastasis by increasing the number of CSCs. CD44 expression is correlated with CSCs, and the aggressiveness of head and neck tumors [22] and CD44 plays a critical role in VE-cadherin expression. [40] For instance, a previously published paper indicated that CD44 plays an important role in controlling the proliferation and apoptosis of capillary endothelial cells through CD31 and VE-cadherin expression. [40] A published study demonstrated that CD44 variant mediates disassembly of endothelial VE-cadherin junction on metastatic melanoma cells. By doing this, CD44 mediates melanoma cell transendothelial migration. [41] CD44 is expressed in the basal cell layer of normal oral mucosa as well as CSCs. [21, 42] A previous study on HNSCC samples found CD44 expression in all samples tested. [22] However, another published study on different histologic grades of OSCC indicated CD44 positivity in 80%-100% of well-differentiated cases, in 60%-85% of moderate-differentiated samples, and in 40%-62% of poor-differentiated cases. The reaction was mostly found at the periphery of tumor islands. [23] According to the results obtained in the current investigation, elevated expression of vimentin was also indicated in tumor cells mainly at the periphery of tumor islands and invasive front in intermediate-and high-grade samples [Figures 7 and 8 ]. Moreover, vimentin positivity was found in some detached cancer cells, especially around the blood vessels, and in the stroma indicating the tumor cells which acquired EMT properties [ Figure 9 ]. Previous studies on HNSCC samples, strong positivity of vimentin was found in the microenvironment. The authors proposed that cancer cell mobility enhances cancer progression and metastasis. [43, 44] In other cancers such as colon, breast, and prostate cancers, vimentin expression level was indicative of aggressive cancer behavior and poor prognosis. [45, 46] Recently published work has shown that elevated vimentin expression level is correlated with EMT process of cancers such as breast cancer [47] and is indicative of poor prognosis in OSCC. [44] Furthermore, vimentin expression is associated with esophageal squamous cell carcinoma lymph node metastasis. [28, 29] EMT in an epithelial tumor may be an alternative mechanism of VM formation. [38] On the other hand, it is suggested that CSCs may be involved in vascular formation [13] and EMT to promote tumor cell invasion and metastasis. [14] The current study provides enough evidence that the higher expression levels of CD44 and vimentin at the periphery of tumor islands and invasive front mostly in higher grade samples may indicate that CSC properties are necessary to get EMT properties which, in turn, enhance the cancer metastasis. Taken together, in the current study, some tumor cells especially at the periphery of tumor islands and at invasive front got stained with VE-cadherin, CD44, and vimentin showing that they are CSCs which could get EMT phenotype. In addition, it can be suggested that these cells are involved in VM formation. Collectively, the current study can be another proof for the previous hypotheses regarding the role of CSC, EMT, and VM channels in cancer development and metastasis. Furthermore, the present study provides enough information about some other molecules and pathways in the cancer growth and metastasis in OSCC. More information about the involved molecules and pathways in tumor growth, especially in metastasis can help to design future investigations to provide new drugs to prevent metastasis as the most important reason for death in oral cancer patients.
MVD is another key player in tumor behavior.
In the present study, MVD count was higher in intermediate-and high-grade samples compared to that of low-grade cases. Similar to the current study, a previous study on prostate cancer found a significant association between microvessel count (MVC) and tumor grade. [46] In ACC samples, MVD was correlated significantly with the clinical stage, vascular invasion, and metastasis. [48] 
Conclusion
Our results may disclose a definite relationship between VE-cadherin, CD44 and vimentin expression levels, VM formation, EMT, CSCs, and MVC in OSCC samples. For this reason, it is suggested that VE-cadherin, CD44, and vimentin are related to angiogenesis and VM formation in OSCC, therefore, in tumor progression and metastasis. Recently, antitumor angiogenic therapies have been challenged. The presence of VM may explain the failure of antiangiogenic treatments. [18] Thus, the inhibition of VM formation has become a new strategy for anticancer therapy. Besides, mutations due to a genetic instability and environmental factors make the solid tumors such as OSCC heterogeneous. [49, 50] Heterogeneity enhances tumor formation which may prove CSC hypothesis. [50] It is suggested that these cells give the tumor the ability to be resistant to chemoradiotherapy and metastasize. [51] Identifying the biomarkers of stem cells which acquire EMT characteristics may also improve the development of drugs targeting EMT CSCs. [52] [53] [54] [55] 
